top of page

A chat with AGC Biologics bringing new biopharmaceuticals to market

On July 12 we met with Christoph Winterhalter, Senior Vice President Business Development at AGC Biologics. AGC Biologics is a global CDMO providing pharmaceutical development and manufacturing services for protein-based biologics and cell and gene therapies. With seven facilities and scientists across three continents, the company specializes in mammalian and microbial-based therapeutic proteins, recombinant DNA, plasmid DNA (pDNA), Messenger RNA (mRNA), viral vectors, and genetically engineered cells.

The Heidelberg facility serves as a hub for microbial systems and services in the European market. The site is an excellence center for custom pDNA services and currently is growing its mRNA service line.

Christoph put an accent on the exceptional focus of AGC Biologics to work side by side with customers to jointly delivering reliable and compliant drug substances.

Discover how they can support you in the full interview on-demand


bottom of page